Safety Study of Apixaban in Recent Acute Coronary Syndrome

Completed · Phase 2 · Has a placebo group

Conditions studied: Acute Coronary Syndrome (ACS)

In brief

The purpose of this clinical research study is to determine whether apixaban will be safe in people who have recently had unstable angina or a heart attack.

Key facts

Study ID
NCT00313300
Run by
Bristol-Myers Squibb
People needed
1741
Starts
2006-05-01
Expected to finish
2008-05-01
Last updated by the study team
2015-12-30

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.